BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21109970)

  • 1. Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.
    Blankenstein T; Jückstock J; Shabani N; Kunze S; Brüning A; Bergauer F; Mylonas I
    Oncol Rep; 2011 Jan; 25(1):147-52. PubMed ID: 21109970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line.
    Burges A; Shabani N; Brüning A; Mylonas I
    Arch Gynecol Obstet; 2011 Oct; 284(4):981-8. PubMed ID: 21082187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibin-α subunit in normal and malignant human cervical tissue and cervical cancer cell lines.
    Mylonas I; Dian D
    Oncol Rep; 2011 Oct; 26(4):887-91. PubMed ID: 21743968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines.
    Bergauer F; Brüning A; Shabani N; Blankenstein T; Jückstock J; Dian D; Mylonas I
    J Mol Histol; 2009 Oct; 40(5-6):353-9. PubMed ID: 20033758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
    Kimmich T; Brüning A; Käufl SD; Makovitzky J; Kuhn C; Jeschke U; Friese K; Mylonas I
    Arch Gynecol Obstet; 2010 Aug; 282(2):185-91. PubMed ID: 20012305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolabeling of the inhibin-βA and -βB subunit in normal and malignant human cervical tissue and cervical cancer cell lines.
    Jückstock J; Brüning A; Blankenstein T; Kunze S; Shabani N; Bergauer F; Mylonas I
    Int J Gynecol Cancer; 2010 Oct; 20(7):1117-24. PubMed ID: 21475087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer.
    Käufl SD; Kuhn C; Kunze S; Shabani N; Brüning A; Friese K; Mylonas I
    Arch Gynecol Obstet; 2011 Jul; 284(1):199-207. PubMed ID: 20683603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
    Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
    Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
    Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
    Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin-betaC subunit expression in normal and pathological human placental tissues.
    Mylonas I; Makovitzky J; Kunze S; Brüning A; Kainer F; Schiessl B
    Syst Biol Reprod Med; 2011 Aug; 57(4):197-203. PubMed ID: 21117833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications.
    Mylonas I
    Eur J Cancer; 2010 Sep; 46(13):2485-93. PubMed ID: 20599374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.
    Mylonas I
    Int J Mol Med; 2011 Mar; 27(3):309-18. PubMed ID: 21174065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles.
    Mylonas I; Shabani N; Vogl J; Makovitzky J; Kunze S; Kuhn C; Schulze S; Friese K; Jeschke U
    Anticancer Res; 2007; 27(4A):1995-2000. PubMed ID: 17649811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin/activin-betaC subunit in human endometrial adenocarcinomas and HEC-1a adenocarcinoma cell line.
    Käufl SD; Makovitzky J; Kuhn C; Kunze S; Jeschke U; Mylonas I
    In Vivo; 2010; 24(5):695-8. PubMed ID: 20952735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.
    Mylonas I; Makovitzky J; Fernow A; Richter DU; Jeschke U; Briese V; Gerber B; Friese K
    Arch Gynecol Obstet; 2005 Jun; 272(1):59-66. PubMed ID: 15309402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.
    Hoeing A; Kuhn C; Shabani N; Schulze S; Gingelmaier A; Dian D; Jeschke U; Friese K; Mylonas I
    Anticancer Res; 2007; 27(4A):2005-10. PubMed ID: 17649813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterisation of an antibody for the immunohistochemical detection of inhibin/activin betaE (betaE) in normal human ovarian and placental tissue.
    Mylonas I; Makovitzky J; Shabani N; Gingelmaier A; Dian D; Kuhn C; Schulze S; Kunze S; Jeschke U; Friese K
    Acta Histochem; 2009; 111(4):366-71. PubMed ID: 19195688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibin-βA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation?
    Mylonas I
    Arch Gynecol Obstet; 2011 Aug; 284(2):467-76. PubMed ID: 20865419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of inhibins in the endometrial carcinoma cell line RL-95-2 after stimulation with cortisol and estradiol.
    Vogl J; Höing A; Schulze S; Kuhn C; Wiest I; Shabani N; Jeschke U; Mylonas I; Friese K
    Anticancer Res; 2007; 27(4A):1989-93. PubMed ID: 17649810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.